Vertex Pharma

VRTX

----

Current ValuationThe current P/E ratio is 28.96, within the reasonable range, cheaper than 63.22% of the time in the past 1 years, and the industry ranks 45/602, the industry Median -2.07.

28.96xP/E

Stock price$503.25Earnings per share$17.38

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

020406080

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
AMGNUSAmgen	25.19x	10.67%	$220.28B
VRTXUSVertex Pharma	28.96x	36.48%	$127.55B
REGNUSRegeneron Pharma	17.59x	7.98%	$76.14B
ARGXUSArgenx	29.85x	37.17%	$51.20B
UTHRUSUnited Therap	17.43x	6.52%	$22.85B
GMABUSGenmab A/S	28.13x	26.27%	$22.17B
ASNDUSAscendis Pharmac	17.01x	467.73%	$14.65B
EXELUSExelixis	16.99x	16.33%	$14.62B
NBIXUSNeurocrine Biosciences	20.35x	50.54%	$14.36B
TGTXUSTG Therap	18.49x	64.86%	$8.16B
CDNAUSCaredex	28.99x	618.00%	$3.22B
PBYIUSPuma BioTech	19.26x	37.70%	$514.65M
KMDAUSKamada	20.16x	36.43%	$448.70M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.